ABSTRACT
Accessory ossicles are small noncalcified, calcified or ossified structures found throughout the body, often noted as incidental findings. Specifically in the foot and ankle, there are at least 24 different ossicles described the majority of which are incidental. However, there are accessory ossicles that can be symptomatic, leading to significant pain and discomfort. While many of the symptomatic ossicles have been described in the literature, there are several that are under-recognized or under-reported for example, os interphalangeus and os calcaneus secundarius syndromes. This manuscript will review common and uncommon accessory ossicles including painful os peroneum, os naviculare, os calcaneus secundarius, os trigonum and os interphalangeus syndromes as well as medial sesamoiditis, with attention to the clinical and imaging findings and with an outline of the current management.
Subject(s)
Ankle , Bone Diseases , Calcaneus , Foot , Humans , Syndrome , Foot Diseases , Ankle JointABSTRACT
ABSTRACT: A 77-year-old man with a history of chronic lower back pain, and prior spinal fusion surgery X2 was referred for 99m Tc-WBC Study for evaluation of worsening back pain and cervical radiculopathy to rule out any signs of infection. The patients white blood cells were tagged with 99m Tc-HMPAO (hexamethylpropylene amine oxime), and planar and SPECT/CT imaging was performed at 4 and 24 hours. 99m Tc-WBC Study showed no abnormal isotope localization in the spine; however, there was an incidental finding of bilateral increased soft tissue uptake in axillary lymph nodes. Medical history revealed intramuscular injection of second and third dose of Moderna mRNA COVID-19 vaccine in bilateral deltoids approximately 11 and 5 months before scan.
Subject(s)
COVID-19 Vaccines , COVID-19 , Radiopharmaceuticals , Aged , Humans , Male , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Leukocytes , Lymph Nodes/diagnostic imaging , Technetium Tc 99m Exametazime , VaccinationABSTRACT
ABSTRACT: Intra-arterial injection of radioactive isotope 90-yttrium 90 Y has been used for elective internal radiation therapy for the treatment of localized hepatocellular carcinoma deemed surgically unresectable. It has also been used to treat intrahepatic cholangiocarcinoma and colorectal cancer that has metastasized to the liver. To prepare for 90 Y treatment, preprocedural mapping via hepatic angiography and 99m Tc-macroaggregated albumin liver lung shunt study followed by postprocedural 90 Y SPECT/CT is essential to ensure a targeted therapy. Therapy is contraindicated if lung shunt fraction is greater than 20% for SIR-Spheres. Anatomic variation in hepatic angiography may be present that can lead to complications if unaccounted for.
Subject(s)
Carcinoma, Hepatocellular , Embolization, Therapeutic , Liver Neoplasms , Humans , Liver Neoplasms/radiotherapy , Technetium Tc 99m Aggregated Albumin , Tomography, Emission-Computed, Single-Photon , Radiopharmaceuticals , Carcinoma, Hepatocellular/radiotherapy , Arteries , Albumins , Yttrium Radioisotopes/therapeutic use , Microspheres , Retrospective StudiesSubject(s)
COVID-19 , Decision Support Systems, Clinical , Humans , COVID-19/epidemiology , SARS-CoV-2ABSTRACT
With the uncertain physical and mental health implications of COVID-19 infection, companies have taken a myriad of actions that aim to reduce the risk of employees contracting the virus, with most grounded in reducing or eliminating in-person interactions. Our preliminary analysis indicates that while there is some data to support modelling absenteeism, there are gaps in the available evidence, requiring the use of assumptions that limit precision and efficacy for decision support. Improved data on time-to-recovery after hospitalization, absenteeism due to family or other household member illness, and mental health's impact on returning to work will support the development of more robust absenteeism models and analytical approaches.